We conducted a
psychotherapeutic examination of the use of definitive drug testing (liquid
chromatography with tandem mass spectrometry) in the treatment of substance use
disorders (SUD). Employing a generic qualitative method (Caelli et al. in International Journal of
Qualitative Methods, 2(2), 2003; Merriam,
2009) we asked SUD counselors to provide narratives about cases where drug
testing had revealed new or unexpected information about clients’ drug-taking
behaviors. Semi-structured interviews with 12 SUD counselors were conducted by
phone and analyzed for themes derived from the literature. These counselors
reported many new positive drug tests in clients previously believed to be
adherent with treatment. Key themes assessed in counselors’ narratives included
initial client denial that was often followed by later acknowledgement of
relapse and increased motivation, at times presenting new opportunities for
clients to engage in treatment and enhance the therapeutic alliance. These
results suggest that definitive drug testing can be used in a non-stigmatizing
and therapeutic manner.
...As captured in counselors’ narratives and supported by the
brief analysis of client-cognitive change, denial (Blume and Marlatt 2009; Levin 1998) appears to have temporal variability,
suggesting opportunities and targets for change in the course of treatment.
Other aspects of denial should be considered as well. For example, clients
might have outwardly denied continued use revealed by definitive drug testing,
despite being aware of the truth. This might be consistent with a fear of
potential legal consequences. Alternatively, some cases of denial may have
involved self-deception, or maintaining a lack of awareness of the true extent
of their own drug-use behaviors. In this sense, shifts in denial may, at times,
be associated with changes in awareness. By extension, shifts in denial might
also be related to motivation, in that progressing through levels of readiness
to change may be related to shifts in awareness and opportunities to observe
oneself engaging in new behaviors (Prochaska et al. 1992)...
A less expected but potentially important theme emerging
from these counselors’ stories was that individual differences in clients’
traits and temporal circumstances seemed to impact the clinical effects of drug
testing at times. For example, in a few cases in which the clients seemed to
have more of an antisocial disposition or a lower readiness to change, changes
in drug-use behaviors may have been relatively superficial, appearing more
connected to the immediate goal of completing the program (Prochaska et al. 1992). However, particularly instructive was
the perspective of one counselor who identified the use of clinical drug
testing as key during a potentially sensitive period of relapse risk when
clients are transitioning from highly structured and controlled environments to
ones with greater autonomy. As this is not an unusual circumstance, it may
represent an opportunity for counselors to better identify changing patterns of
risk factors in their clients that could be addressed with enhanced monitoring
and treatment. An important area of future inquiry will be to examine a broader
range of traits and situations that impact the therapeutic effects of clinical drug
testing...
Full article at: http://goo.gl/rFHBF4
By: Adam Rzetelny, Barbara Zeller, Nicholas Miller, Kathy Egan City, Kenneth L. Kirsh, and Steven D. Passik
Millennium
Health, 16980 Via Tazon, San Diego, CA 92127 USA
Housing
Enterprise for the Less Privileged/Project Samaritan Inc (HELP/PSI), New York,
NY USA
Millennium
Research Institute, San Diego, CA USA
Adam Rzetelny, Phone: 646-599-5222, Email: gro.etutitsnihcraesermuinnellim@ynletezr.mada.
Corresponding
author.
More at: https://twitter.com/hiv insight
No comments:
Post a Comment